慢性腎臟病患者高血壓控制的新進展

Hypertension in Chronic Kidney Disease Patients: An Update

許善閔(Shan-Min Hsu) ； 郭美娟(Mei-Chuan Kuo)

《腎臟與透析》 29卷3期 (2017/09) Pp. 127-131

https://doi.org/10.6340/KD.2017.29(3).06

摘要

高血壓常被稱為「沈默的殺手」，原因就是高血壓常常會造成致命性的併發症，或造成其他器官的異常，使得患者的生活品質惡化。而高血壓與慢性腎臟病之間也有互為因果的密切關係，是慢性腎臟病患者死亡的常見原因。因此，慢性腎臟病患者的高血壓控制一直是非常重要的課題之一。自從2012年的Kidney Disease: Improving Global Outcomes (KDIGO)血壓控制指引出版後，國家衛生研究院也在2015年與腎臟醫學會合作，共同出版了2015台灣慢性腎臟病臨床診療指引。本文將整理自2015年後慢性腎臟病患者高血壓治療的共識，並更新高血壓治療的最新進展與未來趨勢。

關鍵字

慢性腎臟病 ； 高血壓 ； 動態血壓監測 ； 頑固性高血壓 ； 腎動脈交感神經阻斷術

並列摘要

Hypertension is often called ＂silent killer＂ because hypertension often causes fatal complications or organ dysfunction, which make deterioration of patient's quality of life. Chronic kidney disease (CKD) also has close relations with hypertension, and hypertension is also one of the common cause of death in CKD patients. Therefore, hypertension control in CKD patients has been one of the most important issues. Since the 2012 Kidney Disease: Improving Global Outcomes (KDIGO) blood pressure control guidelines published, the National Institutes of Health and Taiwan Society of Nephrology also co-published Taiwan Chronic Kidney Disease Clinical Guidelines in 2015. This article will summarize the consensus and updates of CKD patients with hypertension about the latest advances and future trends.

並列關鍵字

chronic kidney disease ； hypertension ； ambulatory blood pressure monitoring ； resistant hypertension ； renal artery sympathetic nerve denervation